(Q43853422)

27 November 2017

title

Skin pretreatment and the use of transdermal clonidine (English)

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90062-3

4 December 2022

author name string

M. K. Ito

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1831005

4 December 2022

D. T. O'Connor

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1831005

4 December 2022

language of work or name

English

0 references

publication date

1 July 1991

1 reference

27 November 2017

18 July 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1831005

full work available at URL

4 December 2022

https://api.elsevier.com/content/article/PII:0002934391900623?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90062-3

https://api.elsevier.com/content/article/PII:0002934391900623?httpAccept=text/plain

4 December 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90062-3

American Journal of Medicine

4 December 2022

published in

1 reference

27 November 2017

volume

91

1 reference

27 November 2017

issue

1A

1 reference

27 November 2017

page(s)

42S-49S

1 reference

Rationale for rate-controlled drug delivery of cardiovascular drugs by the transdermal route

27 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90062-3

Transdermal clonidine for hypertensive patients

4 December 2022

2

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90062-3

Pharmacokinetics and pharmacodynamics of transdermally administered clonidine

4 December 2022

5

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90062-3

Relationship between the cardiovascular effects and steady-state kinetics of clonidine in hypertension. Demonstration of a therapeutic window in man

4 December 2022

6

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90062-3

Transdermal administration of clonidine: a new approach to antihypertensive therapy

4 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90062-3

Clonidine: irritant and allergic contact dermatitis assays

4 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90062-3

Allergic contact dermatitis with transdermal clonidine

4 December 2022

10

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90062-3

Skin reactions to long-term transdermal clonidine

4 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90062-3

Pharmacokinetics of transdermally delivered clonidine.

4 December 2022

18

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90062-3

The effect of penetration enhancers on the kinetics of percutaneous absorption

4 December 2022

20

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90062-3

Optimization of bioavailability of topical steroids: penetration enhancers under occlusion

4 December 2022

21

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90062-3

4 December 2022

Identifiers

1 reference

27 November 2017

1 reference